Company News

2002 ◽  
Vol 06 (01) ◽  
pp. 3-12 ◽  
Keyword(s):  
Drug Delivery ◽  
Gene Therapy ◽  
Clinical Trials ◽  
Hong Kong ◽  
Drug Delivery System ◽  
Delivery System ◽  
Bt Cotton ◽  
Medical Systems ◽  
Over The Counter ◽  
Antibody Technology

India’s Nath Seeds Ties up with Chinese Biotech Firm for Bt Cotton. Japan’s Takara Grants Molmed Right to Use RetroNectin for Gene Therapy. Sumitomo to Access LifeSpan’s GPCR Expression and Localization Database. Wyeth Lederle Japan Transfers Over-the-counter Drugs to Takeda. Kyowa Hakko Develops New Antibody Technology. Australia’s BTF Completes Prototype for Precise Culture Based Microorganisms. Novogen to Start Phenoxodiol Clinical Trials in Australia. China Investigates Fault in US-made Tempo Pacemakers. Japan Drugmakers to Boost Sales in China. YuHan at Forefront of Pharmaceuticals in Korea. Eli Lilly Opens Asian Headquarters in Hong Kong. DSM Produces Semi-synthetic Penicillin in China. World Diagnostics to Sell Test Kits in India and Vietnam. AMDL Reports Disappointing Sales from Asian Distributor. Taiwan University and AbGenomics to Develop Proprietary Biomedical Platforms. Omeros Medical Systems and Singapore Institute to Develop New Drug Delivery System.

Hypoxia-triggered gene therapy: a new drug delivery system to utilize photodynamic-induced hypoxia for synergistic cancer therapy

2018 ◽  
Vol 6 (40) ◽  
pp. 6424-6430 ◽  
Author(s):  
Caixia Huang ◽  
Jing Zheng ◽  
Dandan Ma ◽  
Na Liu ◽  
Cong Zhu ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Gene Therapy ◽  
Cancer Therapy ◽  
Drug Delivery System ◽  
Delivery System ◽  
New Drug

An new drug delivery system to utilize the photodynamic-induced hypoxia for synergistic cancer therapy is proposed in this paper.

scholarly journals AN OVERVIEW OF CLINICAL TRIALS ON VACCINE OF COVID-19 UNDER NOVEL DRUG DELIVERY SYSTEM

2021 ◽  
Vol 21 (No 1) ◽  
Author(s):  
Mayuri. P. Pol ◽  
Gayatri. C. Mahajan ◽  
Suhas. K. Khairnar ◽  
Dhananjay. M. Patil ◽  
Vinod. A. Bairagi
Keyword(s):  
Drug Delivery ◽  
Clinical Trials ◽  
Drug Delivery System ◽  
Delivery System ◽  
Virus Disease ◽  
Viral Disease ◽  
World Health ◽  
Ongoing Research ◽  
Novel Drug Delivery System ◽  
Novel Drug

The Corona virus disease 2019 (COVID-19) has discovered its underlying foundations from Wuhan (China). Coronavirus is brought about by a novel COVID SARS-CoV2, recently named as 2019-nCoV. Coronavirus has spread across the globe and pronounced as pandemic by World Health Organization (WHO) 0n the 11th March, 2020 as of now, there is no standard medication or vaccine accessible for the treatment, so repurposing of existing medication is the solitary arrangement. vaccine are the arrangements given to patients to summon invulnerable reactions prompting the creation of antibodies (humoral) or cell-interceded reactions that will battle irresistible specialists or non-irresistible conditions, for example, malignancies. Disturbing safety profile of live vaccines, weak immunogenicity of sub-unit vaccines and immunization, failure due to poor patient compliance to booster doses which should potentiate prime doses are rarestoutexplanations, which required the progress of novelgroup of preventive and therapeutic vaccines to encourage effective vaccination. Endeavors are being made to convey immunizations through transporters as they control the spatial and worldly introduction of antigens to invulnerable framework consequently prompting their supported delivery and focusing on. Henceforth, lower dosages of frail immunogens can be successfully coordinated to invigorate safe reactions and kill the requirement for the organization of prime and supporter portions as a section vaccine regimen. Novel Drug Delivery System (NDDS) will be soon for resting of medications. The part of different NDDS in resting of existing medications for treatment of different viral disease, and their importance in COVID-19 has talked about in this paper. It focuses on the currently ongoing research in the implementation and clinical trials on vaccine in the usage of NDDS in COVID-19. In addition, it portrays the part of Liposomes, Virosomes and DNA based vaccine drug delivery advancement for COVID-19

Programmed Packaging: A New Drug Delivery System and its Application to Gene Therapy

2008 ◽  
pp. 1521-1536 ◽  
Author(s):  
Kentaro Kogure ◽  
Hidetaka Akita ◽  
Hiroyuki Kamiya ◽  
Hideyoshi Harashima
Keyword(s):  
Drug Delivery ◽  
Gene Therapy ◽  
Drug Delivery System ◽  
Delivery System ◽  
New Drug

The Physiology of the Liposome

Physiology ◽  
1989 ◽  
Vol 4 (4) ◽  
pp. 146-151 ◽  
Author(s):  
G Gregoriadis
Keyword(s):  
Drug Delivery ◽  
Clinical Trials ◽  
Drug Delivery System ◽  
Delivery System ◽  
Wide Spectrum ◽  
Experimental Animals ◽  
And Control

Understanding of the behavior and control of liposomes in vivo has led to their successful use as a drug delivery system in the treatment or prevention of a wide spectrum of diseases in experimental animals and, more recently, in clinical trials.

scholarly journals DNA/liposome as drug delivery system in the gene therapy.

1995 ◽  
Vol 10 (6) ◽  
pp. 399-403 ◽  
Author(s):  
Masaaki Mizuno ◽  
Jun Yoshida
Keyword(s):  
Drug Delivery ◽  
Gene Therapy ◽  
Drug Delivery System ◽  
Delivery System

scholarly journals Drug delivery system for cancer gene therapy-A review.

2000 ◽  
Vol 15 (1) ◽  
pp. 32-38
Author(s):  
Yoshiro Niitsu ◽  
Minoru Takahashi ◽  
Yasushi Sato
Keyword(s):  
Drug Delivery ◽  
Gene Therapy ◽  
Drug Delivery System ◽  
Delivery System ◽  
Cancer Gene Therapy ◽  
Cancer Gene
Sign in / Sign up

Export Citation Format

Share Document